These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37611949)

  • 1. "Immune mechanisms in fibrotic pulmonary sarcoidosis". P. Weeratunga, D.R. Moller and L-P. Ho.
    Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37611949
    [No Abstract]   [Full Text] [Related]  

  • 2. "Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis." Bridget F. Collins and Ganesh Raghu.
    Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722893
    [No Abstract]   [Full Text] [Related]  

  • 3. "Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms." S. Malenfant, M. Lebret, É. Breton-Gagnon,
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38355152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2016 Mar; 25(139):99. PubMed ID: 26929428
    [No Abstract]   [Full Text] [Related]  

  • 5. "Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension." Irene M. Lang, Sean P. Gaine. Eur Respir Rev 2015; 24: 630-641.
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28049123
    [No Abstract]   [Full Text] [Related]  

  • 6. "Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice." Stephen Y. Chan and Lewis J. Rubin.
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367412
    [No Abstract]   [Full Text] [Related]  

  • 7. "The therapy of idiopathic pulmonary fibrosis: what is next?" Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi,
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31554706
    [No Abstract]   [Full Text] [Related]  

  • 8. "Is bronchiectasis really a disease?" Michal Shteinberg, Patrick A. Flume and James D. Chalmers.
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32051170
    [No Abstract]   [Full Text] [Related]  

  • 9. "Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis." Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58-64.
    Eur Respir Rev; 2015 Sep; 24(137):545. PubMed ID: 26324819
    [No Abstract]   [Full Text] [Related]  

  • 10. "Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis." Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown.
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29653947
    [No Abstract]   [Full Text] [Related]  

  • 11. "Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis." M. Kolb, B. Crestani and T.M. Maher.
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38537950
    [No Abstract]   [Full Text] [Related]  

  • 12. "Lung cancer survival in Norway, 1997-2011: from nihilism to optimism." Yngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, Kristian Bartnes and Bjørn Møller. Eur Respir J 2016; 47: 275-287.
    Eur Respir J; 2016 Apr; 47(4):1297. PubMed ID: 27037324
    [No Abstract]   [Full Text] [Related]  

  • 13. "Cardiovascular disease and COPD: dangerous liaisons." Klaus F. Rabe, John R. Hurst and Samy Suissa.
    Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30463874
    [No Abstract]   [Full Text] [Related]  

  • 14. "Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis." Ana Machado, Pedro Matos Silva, Vera Afreixo, Cátia Caneiras, Chris Burtin and Alda Marques.
    Eur Respir Rev; 2021 Mar; 30(159):. PubMed ID: 33568528
    [No Abstract]   [Full Text] [Related]  

  • 15. "Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD". Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimbaldeston, Divya Mohan and Kian Fan Chung.
    Eur Respir Rev; 2023 Jun; 32(168):. PubMed ID: 37019459
    [No Abstract]   [Full Text] [Related]  

  • 16. "How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?". G. Hardavella, A. Frille, R. Chalela, K.B. Sreter, R.H. Petersen, N. Novoa and H.J. de Koning.
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 39142712
    [No Abstract]   [Full Text] [Related]  

  • 17. From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.
    Bonham CA; Strek ME; Patterson KC
    Curr Opin Pulm Med; 2016 Sep; 22(5):484-91. PubMed ID: 27379967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Cellular mechanisms underlying steroid-resistant asthma." Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro.
    Eur Respir Rev; 2019 Dec; 28(154):. PubMed ID: 31722895
    [No Abstract]   [Full Text] [Related]  

  • 19. Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes.
    Sun K; Fisher JH; Pagnoux C
    Curr Rheumatol Rep; 2022 Aug; 24(8):259-267. PubMed ID: 35794350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling.
    Finlay WH; Stapleton KW; Chan HK; Zuberbuhler P; Gonda I
    J Appl Physiol (1985); 1996 Jul; 81(1):374-83. PubMed ID: 8828688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.